Cargando…
AVT02: An Adalimumab Biosimilar
AVT02 (Hukyndra(®), Libmyris(®)) is a biosimilar of the reference anti-tumour necrosis factor alpha monoclonal antibody adalimumab. It is approved for use in all indications for which reference adalimumab is approved. AVT02 has similar physicochemical and pharmacodynamic properties to those of refer...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576660/ https://www.ncbi.nlm.nih.gov/pubmed/36181655 http://dx.doi.org/10.1007/s40261-022-01196-w |